What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Virus
His primary scientific interests are in Internal medicine, Dengue fever, Immunology, Virology and Retrospective cohort study.
His Internal medicine research incorporates themes from Piperacillin/tazobactam, Piperacillin, Surgery and Carbapenem.
His Piperacillin research is multidisciplinary, incorporating perspectives in Randomized controlled trial, Meropenem, Beta-lactamase, Drug resistance and Ceftriaxone.
His Dengue fever study integrates concerns from other disciplines, such as Viral disease, Confidence interval, Serology, Severity of illness and Pediatrics.
His studies in Virology integrate themes in fields like Antibody, CD8, Communicable disease and Coronavirus.
His biological study spans a wide range of topics, including Case-control study and Dengue hemorrhagic fever.
His most cited work include:
- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. (1058 citations)
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. (447 citations)
- Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. (365 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Dengue fever, Retrospective cohort study, Immunology and Intensive care medicine.
His Internal medicine research focuses on Surgery and how it relates to Platelet transfusion.
His studies examine the connections between Dengue fever and genetics, as well as such issues in Hematocrit, with regards to Abdominal pain.
His Retrospective cohort study research includes themes of Cohort study, Relative risk, Severity of illness, Intensive care unit and Cohort.
His work investigates the relationship between Cohort study and topics such as Prospective cohort study that intersect with problems in Emergency medicine.
His study in Ceftriaxone and Carbapenem are all subfields of Antibiotics.
He most often published in these fields:
- Internal medicine (61.25%)
- Dengue fever (47.70%)
- Retrospective cohort study (35.23%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (61.25%)
- Coronavirus disease 2019 (10.03%)
- Immunology (24.66%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Coronavirus disease 2019, Immunology, Severe acute respiratory syndrome coronavirus 2 and Antibody are his primary areas of study.
Internal medicine is closely attributed to Dengue fever in his research.
David C. Lye interconnects Disease severity, Radiography, Virology, Pneumonia and 2019-20 coronavirus outbreak in the investigation of issues within Coronavirus disease 2019.
His Virology study combines topics in areas such as Epitope and Coronavirus.
His research in Severe acute respiratory syndrome coronavirus 2 intersects with topics in Gastroenterology and Pandemic.
His Antibody research is multidisciplinary, relying on both Virus, Asymptomatic and Convalescence.
Between 2019 and 2021, his most popular works were:
- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. (1058 citations)
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. (447 citations)
- Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. (365 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Virus
David C. Lye spends much of his time researching Coronavirus disease 2019, Virology, Antibody, Severe acute respiratory syndrome coronavirus 2 and 2019-20 coronavirus outbreak.
His Coronavirus disease 2019 research integrates issues from Venous thrombosis, Pediatrics, Disease severity and Acute disseminated encephalomyelitis.
His work deals with themes such as Serology, Respiratory tract infections and Coronavirus, which intersect with Virology.
As part of one scientific family, he deals mainly with the area of Antibody, narrowing it down to issues related to the Virus, and often Open reading frame, Genome and Outbreak.
His research integrates issues of Observational study, Repeat testing, Pandemic, Betacoronavirus and Cohort in his study of 2019-20 coronavirus outbreak.
His research on Pneumonia concerns the broader Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
